Beta-blocker under-use in COPD patients.

about

Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study

P2860

Q59136323-5EFC9D18-700A-4CBB-A09A-618D288CDE33

P2860

Beta-blocker under-use in COPD patients.

Item

http://www.wikidata.org/entity/Q47123558

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Beta-blocker under-use in COPD patients.

@en

Beta-blocker under-use in COPD patients.

@nl

type

Item

label

Beta-blocker under-use in COPD patients.

@en

Beta-blocker under-use in COPD patients.

@nl

prefLabel

Beta-blocker under-use in COPD patients.

@en

Beta-blocker under-use in COPD patients.

@nl

P1476

Beta-blocker under-use in COPD patients.

@en

P2093

Jeremy P Wrobel

http://www.w3.org/2001/XMLSchema#string

Kuan Pin Lim

http://www.w3.org/2001/XMLSchema#string

Michael Musk

http://www.w3.org/2001/XMLSchema#string

Sarah Loughrey

http://www.w3.org/2001/XMLSchema#string

P2860

Cardioselective beta-blockers for chronic obstructive pulmonary disease

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records

Epidemiology and clinical impact of major comorbidities in patients with COPD.

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

P304

3041-3046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S144333

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melanie Lavender

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29089752

http://www.w3.org/2001/XMLSchema#string

P932

5655126

http://www.w3.org/2001/XMLSchema#string

Beta-blocker under-use in COPD patients.

about

P2860

P2860

Beta-blocker under-use in COPD patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932